VIT-2763(2095668-10-1)名称与标识符
名称
英文别名：
FUF66UD0KR;Vamifeport;Vamifeport [INN];vamifeport (proposed INN);GTPL11183;VIT2763;N1C(=NC2=C1C=CC=C2)CCNCCC=1OC=C(N=1)C(=O)NCC1=NC=CC=C1F;2-(2-((2-(1H-Benzimidazol-2-yl)ethyl)amino)ethyl)-N-((3-fluoropyridin-2-yl)methyl)-1,3-oxazole-4-carboxamide;2-[2-[2-(1H-benzimidazol-2-yl)ethylamino]ethyl]-N-[(3-fluoropyridin-2-yl)methyl]-1,3-oxazole-4-carboxamide;4-Oxazolecarboxamide, 2-(2-((2-(1H-benzimidazol-2-yl)ethyl)amino)ethyl;Unii-fuf66UD0KR;VIT-2763;G17499;VIT- 2763-PM1;WHO 11410;Vamifeport [USAN:INN];2-(2-(2-(1H-benzimidazol-2-yl)ethylamino)ethyl)-N-((3-fluoropyridin-2-yl)methyl)-1,3-oxazole-4-carboxamide;EX-A4401;VIT-2763-PM1;2-[2-[2-(1~{H}-benzimidazol-2-yl)ethylamino]ethyl]-~{N}-[(3-fluoranylpyridin-2-yl)methyl]-1,3-oxazole-4-carboxamide;Vamifeport (USAN/INN);4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]-;D12289;2095668-10-1;SZU;Vamifeport [USAN];AKOS040757273;CS-0044182;MS-27013;HY-112220;4-Oxazolecarboxamide, 2-(2-((2-(1H-benzimidazol-2-yl)ethyl)amino)ethyl)-N-((3-fluoro-2-pyridinyl)methyl)-;GLXC-26916;SCHEMBL18764615;DA-68606;CHEMBL4596566;VIT 2763;
标识符
InChIKey：
KNYVRFXIVWUGBZ-UHFFFAOYSA-N
Inchi：
1S/C21H21FN6O2/c22-14-4-3-9-24-17(14)12-25-21(29)18-13-30-20(28-18)8-11-23-10-7-19-26-15-5-1-2-6-16(15)27-19/h1-6,9,13,23H,7-8,10-12H2,(H,25,29)(H,26,27)
SMILES：
FC1=CC=CN=C1CNC(C1=COC(CCNCCC2=NC3C=CC=CC=3N2)=N1)=O
3003949364 
![Methyl N6-[(benzyloxy)carbonyl]-N2-{[(2-methyl-2-propanyl)oxy]carbonyl}-D-lysinate](http://hg.y866.cn/compound/lib/scimg/cas/150/82611-49-2.png "Methyl N6-[(benzyloxy)carbonyl]-N2-{[(2-methyl-2-propanyl)oxy]carbonyl}-D-lysinate")
![N-[(1R)-2-[5-溴-3-[[2-氟-6-(三氟甲基)苯基]甲基]-3,6-二氢-4-甲基-2,6-二氧代-1(2H)-嘧啶基]-1-苯基乙基]氨基甲酸叔丁酯](http://hg.y866.cn/compound/lib/scimg/cas/150/830346-49-1.png "N-[(1R)-2-[5-溴-3-[[2-氟-6-(三氟甲基)苯基]甲基]-3,6-二氢-4-甲基-2,6-二氧代-1(2H)-嘧啶基]-1-苯基乙基]氨基甲酸叔丁酯")
